C
CRVO
CervoMed
4.140
+0.140+3.50%After Hours: 4.140 0.000 0.00%16:04 04/02 EDT
OPEN/PREV CLOSE3.900/3.840
TODAY RANGE3.712-4.140
VOL49.41K
MARKET CAP37.41M
52 WEEK RANGE3.510-13.13
AVG VOL (3M)86.65K
% TURNOVER0.53%
TURNOVER--
P/E (TTM)-1.3546
% RANGE11.15%
EPS(TTM)-2.9824
P/E(FORWARD)-1.7265
P/B2.051
BVPS1.970
DIVIDEND--
P/S9.33
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP25.38M
SHARES OUTSTANDING9.26M
NEXT EARNINGS05/11-05/15
FREE FLOAT6.28M
LOT SIZE1
EX-DATE08/17/2023
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
CervoMed (CRVO) Gets a Buy from JonesTrading
TipRanks·03/23 20:38
CervoMed Posts Investor Presentation Under Regulation FD Disclosure
Reuters·03/23 20:08
Cervomed Inc. Publishes Presentation Factsheet
TipRanks·03/19 20:59
CervoMed Highlights RewinD-LB Phase 2b Biomarker-Driven Results
Dow Jones·03/19 18:42
CervoMed Price Target Maintained With a $31.00/Share by D. Boral Capital
Dow Jones·03/19 18:42
CervoMed Is Maintained at Buy by D. Boral Capital
TipRanks·03/19 11:56
CervoMed’s neflamapimod shows efficacy in dementia with DLB
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.